# Nuvox Pharma, L.L.C.

Canonical: https://abierto.us/vendors/nuvox-pharma-l-l-c-whnyg96udlj8

- UEI: WHNYG96UDLJ8
- CAGE: 51P42
- Location: Tucson, AZ
- Awards in window: 1 (4 transactions), -$393,000 obligated, November 1, 2024 to August 28, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, -$393,000

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): -$393,000

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50123C00034 (definitive contract): -$393,000, Barda - Aspr / Daappo / Barda DCMA. Research and Development - Aoi #19 for the Development of Novel Oxygen Therapeutic NAN02 for Covid19: Extend. https://www.usaspending.gov/award/CONT_AWD_75A50123C00034_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/nuvox-pharma-l-l-c-whnyg96udlj8.